Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

BACKGROUND: In HIV-infected patients, combination antiretroviral therapy (cART) is associated with clinical lipodystrophy (CL) and metabolic abnormalities (MA). This study aimed to evaluate the prevalence of the metabolic syndrome (MS) and its components, and to determine whether patients with or wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Freitas, Paula, Carvalho, Davide, Souto, Selma, Santos, Ana Cristina, Xerinda, Sandra, Marques, Rui, Martinez, Esteban, Sarmento, António, Medina, José Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187742/
https://www.ncbi.nlm.nih.gov/pubmed/21933422
http://dx.doi.org/10.1186/1471-2334-11-246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187742/
https://www.ncbi.nlm.nih.gov/pubmed/21933422
http://dx.doi.org/10.1186/1471-2334-11-246

Ejemplares similares